We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]

Important Changes to the Availability and Conditions of Use for Drugs Containing Calcitonin Calcitonin nasal spray for the treatment of osteoporosis is no longer available in Canada because of new […]

Osteoporosis Canada is saddened to announce the passing of Dr. Timothy M. Murray, founding member of Osteoporosis Canada. Dr. Murray was the Emeritus Professor of Medicine at the University of […]

Stay Informed Latest News Recent news about Osteoporosis and Osteoporosis Canada. VIEW Position Statements Osteoporosis Canada’s rapid response team, made up of members of the Scientific Advisory Council, creates position statements […]